Arthritis drug and remdesivir shortens hospital stays for COVID-19
Arthritis drug may boost remdesivir’s benefits for COVID-19 sufferers: Patients given both drugs spent one day less in the hospital compared to those who only got Gilead’s antiviral Eli Lilly announced Monday that its anti-inflammatory drug baricitinib used in combination with remdesivir showed promising benefit COVID-19 patients who got both drugs in the 1,000-person NIH study were well enough to leave the […]
» Read more